From the labto the hospital

Clinical Nanomedicine and Advanced Therapies Research Centre. Immunology and Immunotherapy Regulation

CIBBIM-Nanomedicina. Regulació immunològica i immunoteràpia

The group focuses on molecular and functional characterisation of different immunoreceptor families. To apply the results of this knowledge, the lines of research are dedicated to assessing the possible role of some of these receptors as diagnostic markers and as targets for different pathologies, including cancer, acute nervous system damage and diabetes. 


This group is also working on modulating the function of some of these receptors to increase the circulation time of specific nanoparticles and vesicles used as therapeutic or even diagnostic tools.

Visit the research group’s page